Prelude Therapeutics
PRLD
#9213
Rank
โ‚น5.80 B
Marketcap
โ‚น105.56
Share price
-4.62%
Change (1 day)
-69.64%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -โ‚น179.02

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น184.73. In 2022 the company made an earnings per share (EPS) of -โ‚น207.71 a decrease over its 2021 EPS that were of -โ‚น206.01.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น179.02-13.81%
2022-โ‚น207.710.83%
2021-โ‚น206.01-61.3%
2020-โ‚น532.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น185.58 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA